NewHydrogen (NEWH) 10-K 24 Mar 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 21, 2014	Jun. 28, 2013
Document and Entity Information:	'	'	'
Entity Registrant Name	'BioSolar Inc,	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Amendment Flag	'false	'	'
Entity Central Index Key	'0001371128	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Common Stock, Shares Outstanding	'	10,187,280	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Public Float	'	'	$3,138,228

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
CURRENT ASSETS	'	'
Cash	$158,350	$42,942
Prepaid expenses	8,303	11,523
TOTAL CURRENT ASSETS	166,653	54,465
PROPERTY AND EQUIPMENT	'	'
Machinery and equipment	81,791	81,791
Less accumulated depreciation	-42,996	-34,793
NET PROPERTY AND EQUIPMENT	38,795	46,998
OTHER ASSETS	'	'
Patents	47,098	41,290
Deposit	770	770
TOTAL OTHER ASSETS	47,868	42,060
TOTAL ASSETS	253,316	143,523
CURRENT LIABILITIES	'	'
Accounts payable	665	9,253
Accrued expenses	50,148	180,594
Derivative liability	361,170	0
Convertible promissory notes less debt discount of $152,928 and $20,369 respectively	194,072	54,631
TOTAL CURRENT LIABILITIES	606,055	244,478
SHAREHOLDERS' DEFICIT	'	'
Preferred stock, $0.0001 par value; 10,000,000 authorized common shares	'	'
Common stock, $0.0001 par value; 500,000,000 authorized common shares 9,041,281 and 6,434,413 shares issued and outstanding, respectively	904	644
Additional paid in capital	6,625,212	5,676,680
Deficit accumulated during the development stage	-6,978,855	-5,778,279
TOTAL SHAREHOLDERS' DEFICIT	-352,739	-100,955
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$253,316	$143,523

BALANCE_SHEETS_Parenthetical

BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Statement of Financial Position	'	'
Preferred Stock, par or stated value	$0.00	$0.00
Preferred Stock, shares authorized	10,000,000	10,000,000
Common Stock, par or stated value	$0.00	$0.00
Common Stock, shares authorized	500,000,000	500,000,000
Common Stock, shares issued	9,041,281	6,434,413
Common Stock, shares outstanding	9,041,281	6,434,413
Convertible Promissory Notes, Debt discount	$152,928	$20,369

STATEMENT_OF_OPERATIONS

STATEMENT OF OPERATIONS (USD $)	12 Months Ended		92 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Income statement	'	'	'
REVENUE	'	'	'
OPERATING EXPENSES	'	'	'
General and administrative expenses	653,903	796,769	5,555,166
Research and development	27,953	78,527	842,310
Depreciation and amortization	8,203	8,055	42,996
TOTAL OPERATING EXPENSES	690,059	883,351	6,440,472
LOSS FROM OPERATIONS BEFORE OTHER INCOME	-690,059	-883,351	-6,440,472
TOTAL OTHER INCOME/(EXPENSES)	'	'	'
Interest income	99	27	87,361
Penalties	'	'	-180
Loss on patent impairment	'	-107,704	-107,704
Gain/(Loss) on change in derivative liability	-188,261	'	-188,261
Interest expense	-322,355	-6,482	-329,599
TOTAL OTHER INCOME/(EXPENSES)	-510,517	-114,159	-538,383
NET LOSS	($1,200,576)	($997,510)	($6,978,855)
BASIC AND DILUTED LOSS PER SHARE	($0.16)	($0.16)	'
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED	7,601,521	6,434,413	'

STATEMENT_OF_SHAREHOLDERS_DEFI

STATEMENT OF SHAREHOLDERS' DEFICIT (USD $)	Preferred Stock	Common Stock		Additional Paid-in Capital	Deficit Accumulated during the Development Stage	Total
Shareholders' Equity, Beginning of Period, Value at Apr. 23, 2006	'	'		'	'	'
Shareholders' Equity, Beginning of Period, Shares at Apr. 23, 2006	'	'		'	'	'
Issuance of common stock for services, Value	'	0	[1]	1	'	1
Issuance of common stock for services, Shares	'	34		'	'	'
Issuance of founders shares for cash, Value	'	197	[2]	14,552	'	14,749
Issuance of founders shares for cash, Shares	'	1,966,653		'	'	'
Issuance of common stock for cash, Value	'	232	[3]	1,439,046	'	1,439,278
Issuance of common stock for cash, Shares	'	2,318,593		'	'	'
Net Loss	'	'		'	-274,361	-274,361
Shareholders' Equity, End of Period, Value at Dec. 31, 2006	'	429		1,453,599	-274,361	1,179,667
Shareholders' Equity, End of Period, Shares at Dec. 31, 2006	'	4,285,280		'	'	'
Issuance of common stock for services, Value	'	2	[4]	212,258	'	212,260
Issuance of common stock for services, Shares	'	16,467		'	'	'
Stock issuance cost	'	'		-2,160	'	-2,160
Issuance of common stock for cash, Value	'	9	[5]	530,991	'	531,000
Issuance of common stock for cash, Shares	'	88,500		'	'	'
Net Loss	'	'		'	-847,706	-847,706
Shareholders' Equity, End of Period, Value at Dec. 31, 2007	'	'		2,194,688	-1,122,067	1,073,061
Issuance of common stock for services, Value	'	0	[6]	25,000	'	25,000
Issuance of common stock for services, Shares	'	3,334		'	'	'
Issuance of common stock for cash, Value	'	5	[7]	389,995	'	390,000
Issuance of common stock for cash, Shares	'	52,000		'	'	'
Net Loss	'	'		'	-947,646	-947,646
Shareholders' Equity, End of Period, Value at Dec. 31, 2008	'	445		2,609,683	-2,069,713	540,415
Shareholders' Equity, End of Period, Shares at Dec. 31, 2008	'	4,445,581		'	'	'
Common stock subscription payable	'	'		'	'	203,000
Issuance of common stock for cash, Value	'	48	[8]	719,952	'	517,000
Issuance of common stock for cash, Shares	'	480,000		'	'	'
Net Loss	'	'		'	-644,601	-644,601
Shareholders' Equity, End of Period, Value at Dec. 31, 2009	'	493		3,329,635	-2,714,314	615,814
Shareholders' Equity, End of Period, Shares at Dec. 31, 2009	'	4,925,581		'	'	'
Issuance of common stock for services, Value	'	3	[9]	87,997	'	88,000
Issuance of common stock for services, Shares	'	26,667		'	'	'
Issuance of common stock for cash, Value	'	22	[10]	449,978	'	450,000
Issuance of common stock for cash, Shares	'	222,222		'	'	'
Net Loss	'	'		'	-919,393	-919,393
Shareholders' Equity, End of Period, Value at Dec. 31, 2010	'	518		3,867,610	-3,633,707	234,421
Shareholders' Equity, End of Period, Shares at Dec. 31, 2010	'	5,174,470		'	'	'
Issuance of common stock for cash, Value	'	36	[11]	738,265	'	738,301
Issuance of common stock for cash, Shares	'	361,694		'	'	'
Stock compensation cost	'	'		434,245	'	434,245
Net Loss	'	'		'	-1,147,062	-1,147,062
Shareholders' Equity, End of Period, Value at Dec. 31, 2011	'	554		5,040,120	-4,780,769	259,905
Shareholders' Equity, End of Period, Shares at Dec. 31, 2011	'	5,536,164		'	'	'
Issuance of founders shares for cash, Value	'	33		-33	'	'
Issuance of common stock for warrants through a cashless exercise, Shares	'	332,602		'	'	332,602
Issuance of common stock for subscription receivable, Value	'	2	[12]	11,599	'	11,601
Issuance of common stock for subscription receivable, Shares	'	17,577		'	'	'
Cancellation of subscription receivable, Value	'	-2		-11,599	'	-11,601
Cancellation of subscription receivable, Shares	'	-17,577		'	'	'
Beneficial conversion feature	'	'		24,953	'	24,953
Issuance of common stock for cash, Value	'	57	[13]	337,808	'	337,865
Issuance of common stock for cash, Shares	'	565,647		'	'	'
Stock compensation cost	'	'		273,832	'	273,832
Net Loss	'	'		'	-997,510	-997,510
Shareholders' Equity, End of Period, Value at Dec. 31, 2012	'	644		5,676,680	-5,778,279	-100,955
Shareholders' Equity, End of Period, Shares at Dec. 31, 2012	'	6,434,413		'	'	'
Beneficial conversion feature	'	'		-20,369	'	-20,369
Issuance of common stock for cash, Value	'	153	[14]	398,138	'	398,291
Issuance of common stock for cash, Shares	'	1,530,631		'	'	'
Issuance of common shares for converted promissory notes at fair value, Value	'	107		436,766	'	436,873
Issuance of common shares for converted promissory notes at fair value, Shares	'	1,076,237		'	'	1,076,237
Stock compensation cost	'	'		133,997	'	133,997
Net Loss	'	'		'	-1,200,576	-1,200,576
Shareholders' Equity, End of Period, Value at Dec. 31, 2013	'	$904		$6,625,212	($6,978,855)	($352,739)
Shareholders' Equity, End of Period, Shares at Dec. 31, 2013	'	9,041,281		'	'	'
[1]	(issued at $0.03 per share )
[2]	(issued at $0.0075 per share )
[3]	(in May 2006 issued at prices between $0.225 and $3.00 per share )
[4]	(issued at prices between $7.80 and $16.20 per share )
[5]	(issued at $6.00 per share )
[6]	(issued at $7.50 per share )
[7]	(17,333 common shares issued at $7.50 per share )
[8]	(in September 2009 for cash issued at $1.50 per share )
[9]	(issued at a fair value of $3.30 per share)
[10]	(prices ranging from $1.80 to $2.40 per share)
[11]	(prices ranging between $1.725 and $2.25 per share)
[12]	(price of $0.66 per share)
[13]	(prices ranging between $0.55 and $0.70 per share)
[14]	(at prices of $0.22 and $0.28 per share)

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended		92 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'	'
Net loss	($1,200,576)	($997,510)	($6,978,855)
Adjustment to reconcile net loss to net cash used in operating activities	'	'	'
Depreciation and amortization expense	8,203	8,055	42,996
Issuance of stock for services	'	'	325,260
Stock compensation cost	133,997	273,832	842,074
Beneficial conversion feature	-4,584	4,584	'
Loss on patent impairment	'	107,704	107,704
(Gain)/loss on change in derivative liability	188,261	'	188,261
Amortization of debt discount recognized as interest expense	307,442	'	307,442
Prepaid expenses	3,220	19,274	-8,303
Deposits	'	'	-770
Accounts payable	-8,588	4,876	665
Accrued expenses	118,050	167,449	298,644
NET CASH USED IN OPERATING ACTIVITIES	-454,575	-411,736	-4,874,882
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'	'
Purchase of equipment	'	-2,582	-81,791
Patent expenditures	-5,808	-8,027	-154,802
NET CASH USED IN INVESTING ACTIVITIES	-5,808	-10,609	-236,593
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'	'
Proceeds from convertible promissory notes	177,500	75,000	252,500
Proceeds from common stock subscription payable	'	'	203,000
Proceeds from issuance of common stock, net of issuance cost	398,291	337,865	4,814,325
NET CASH PROVIDED IN FINANCING ACTIVITIES	575,791	412,865	5,269,825
NET INCREASE/(DECREASE) IN CASH	115,408	-9,480	158,350
CASH, BEGINNING OF PERIOD	42,942	52,422	'
CASH, END OF PERIOD	158,350	42,942	158,350
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION	'	'	'
Interest paid	597	'	1,859
Taxes paid	'	'	'
SUPPLEMENTAL SCHEDULE OF NON-CASH TRANSACTIONS	'	'	'
Common stock issued for client debt	$436,873	'	$436,873

1_Organization_and_Line_of_Bus

1. Organization and Line of Business	12 Months Ended
	Dec. 31, 2013
Notes	'
1. Organization and Line of Business	'
	1.    ORGANIZATION AND LINE OF BUSINESS
	Organization
	BioSolar, Inc. (the "Company") was incorporated in the state of Nevada on April 24, 2006.  The Company, based in Santa Clarita, California, began operations on April 25, 2006 to develop and market Photovoltaic solar technology products.
	Line of Business
	The Company is currently marketing bio-based photovoltaic back sheet based on its innovative technology to produce bio-based photovoltaic components from renewable plant sources that will reduce the cost per watt of Photovoltaic solar modules. The bio-based photovoltaic back sheets are directly marketed to photovoltaic module manufacturers as well as manufacturer’s representatives.
	Going Concern
	The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business.  The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern.  The Company has not generated significant revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern.  The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion.  The Company received a purchase order from a specialty PV manufacturer during 2013, and expect to receive additional orders during 2014. The Company has obtained funds from its shareholders since its inception through the year ended December 31, 2013. The Company has also obtained funding from new investors. Management believes existing shareholders and prospective new investors will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core of business. There is no assurance that the Company will be able to continue raising the required capital for its operations.

2_Summary_of_Significant_Accou

2. Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Notes	'
2. Summary of Significant Accounting Policies	'
	2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	This summary of significant accounting policies of the Company are presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.
	Development Stage Activities and Operations
	The Company is in its initial stages of formation and has not had significant revenues. A development stage activity is one in which all efforts are devoted substantially to establishing a new business and even if planned principal operations have commenced, revenues are insignificant.
	Revenue Recognition
	The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date, the Company has not had significant revenues and is in the development stage.
	Cash and Cash Equivalent
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
	Investments
	Certificate of Deposits with banking institutions are short-term investments with initial maturities of more than 90 days. The carrying amount of these investments is a reasonable estimate of fair value due to their short-term nature.
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements.  Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, and the fair value of stock options. Actual results could differ from those estimates.
	Property and Equipment
	Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives:
	Computer equipment	5 Years
	Machinery & equipment	10 Years
	Depreciation expense for the years ended December 31, 2013 and 2012 was $8,203 and $8,055, respectively.
	Intangible Assets
	Intangible assets consist of patents that are initially measured at the lower of cost or fair value.  The patents are deemed to have an indefinite life and are not amortized. The patents are assessed annually for impairment, or whenever conditions indicate the asset may be impaired, and any such impairment will be recognized in the period identified.
	Stock-Based Compensation
	The Company measures the cost of employee services received in exchange for an equity award based on the grant-date fair value of the award. All grants under our stock-based compensation programs are accounted for at fair value and that cost is recognized over the period during which an employee is required to provide service in exchange for the award (the vesting period).
	Compensation expense for options granted to non-employees is determined in accordance with the standard as the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measured. Compensation expense for awards granted to non-employees is re-measured each period.
	Determining the appropriate fair value of the stock-based compensation requires the input of subjective assumptions, including the expected life of the stock-based payment and stock price volatility.  The Company uses the Black-Scholes option-pricing model to value its stock option awards which incorporate the Company’s stock price, volatility, U.S. risk-free rate, dividend rate, and estimated life.
	Loss per Share Calculations
	Loss per Share dictates the calculation of basic earnings per share and diluted earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. No shares for employee options or warrants were used in the calculation of the loss per share as they were all anti-dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the years ended December 31, 2013 and 2012, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company has excluded 611,667 exercisable options and 245,000 warrants for the year ended December 31, 2013. The Company has excluded 236,667 exercisable options and 245,000 warrants for the year ended December 31, 2012.
		For the years ended
		December 31,
		2013	2012
	(Loss) to common shareholders (Numerator)	($1,200,576)	($997,510)
	Basic and diluted weighted average number of common shares outstanding (Denominator)	7,601,521	6,434,413
	Fair Value of Financial Instruments
	Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2013, the amounts reported for cash, inventory, prepaid expenses, accounts payable, and accrued expenses, approximate the fair value because of their short maturities.
	We adopted ASC Topic 820 (originally issued as SFAS 157, “Fair Value Measurements”) for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:
	·       Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
	·       Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
	·       Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at  December 31, 2013:
		Total	(Level 1)	(Level 2)	(Level 3)
	Assets	$-	$-	$-	$-
	Total assets measured at fair value	$-	$-	$-	$-
	Liabilities
	Derivative Liability	$361,170	$-	$-	$361,170
	Total liabilities measured at fair value	$361,170	$-	$-	$361,170
	The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:
	Beginning balance as of January 1, 2013	$-
	Fair value of derivative liabilities issued	455,786
	Conversion of notes payable	-282,877
	Loss on change in derivative liability	188,261
	Ending balance as of December 31, 2013	$361,170
	Research and Development
	Research and development costs are expensed as incurred.  Total research and development costs were $27,953 and $78,527 for the years ended December 31, 2013 and 2012, respectively.
	Income Taxes
	Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.
	When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained.  The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.  Tax positions taken are not offset or aggregated with other positions.  Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority.  The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.
	Recently Issued Accounting Pronouncements
	Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying consolidated financial statements.

3_Capital_Stock

3. Capital Stock	12 Months Ended
	Dec. 31, 2013
Notes	'
3. Capital Stock	'
	3.     CAPITAL STOCK
	On July 10, 2013, the Company filed an amendment to its Articles of Incorporation to increase its authorized common and preferred stock to 500,000,000 shares of common stock, with a par value of $0.0001, and 10,000,000 preferred stock, with a par value of $0.0001.
	During the year ended December 31, 2013, the Company issued 504,773 shares of common stock at a price of $0.22 per share for cash of $111,050;issued 1,025,858 shares of common stock at a price of $0.28 per share for cash of $287,241.Also, the Company issued 1,076,237 shares of common stock at prices ranging from $0.10 to $0.39, for conversion of $147,500 in convertible promissory notes, including $6,497 for accrued interest.
	During the year ended of December 31, 2012, the Company issued 376,818 shares of common stock at a price of $0.55 per share for cash of $207,250; issued 37,880 shares of common stock at a price of $0.66 per share for cash of $25,000; issued 18,812 shares of common stock for a subscription receivable in the amount of $12,416 during the period ended March 31, 2012, of which $11,601 was refunded to the investor and 17,577 shares of common stock were cancelled during the period ended September 30, 2012. The remaining 1,235 shares of common stock were purchased at a price of $0.66 per share for cash of $815. In addition the Company issued 149,714 shares of common stock at a price of $0.70 per share for cash of $104,799. Also, through a cashless exercise the Company issued 332,602 shares of common stock for stock purchase warrants.

4_Stock_Options_and_Warrants

4. Stock Options and Warrants	12 Months Ended
	Dec. 31, 2013
Notes	'
4. Stock Options and Warrants	'
	4.    STOCK OPTIONS AND WARRANTS
	During the year ended December 31, 2013, the Company issued the following stock options:
	On March 1, 2013, the Board of Directors of the Company granted non-qualified stock options to purchase 600,000 shares of common stock of the Company to its employees, directors and certain consultants. The stock options vest at various times, and are exercisable for a period of five years from the date of grant at an exercise price of $0.40 per share, the market value of the Company’s common stock on the date of grant.
	During the year ended December 31, 2012, the Company did not grant any stock options.
		12/31/13	12/31/12
	Risk free interest rate	0.75%	2.14%
	Stock volatility factor	82.00%	1.00%
	Weighted average expected option life	5 years	5 years
	Expected dividend yield	None	None
		12/31/13		12/31/12
			Weighted		Weighted
		Number	average	Number	average
		of	exercise	of	exercise
		Options	price	Options	price
	Outstanding, beginning of period	236,667	$4.05	236,667	$4.05
	Granted	600,000	0.4	-	-
	Exercised	-	-	-	-
	Expired	-	-	-	-
	Outstanding, end of period	836,667	$1.43	236,667	$4.05
	Exercisable at the end of period	611,667	$1.81	225,001	$4.05
	The weighted average remaining contractual life of options outstanding as of December 31, 2013 was as follows:
				Weighted
				Average
		Stock	Stock	Remaining
	Exercisable	Options	Options	Contractual
	Prices	Outstanding	Exercisable	Life (years)
	$4.05	236,667	236,667	2.23
	$0.40	600,000	375,000	4.17
	Total	836,667	611,667
	The weighted average remaining contractual life of options outstanding as of December 31, 2012 was as follows:
				Weighted
				Average
		Stock	Stock	Remaining
	Exercisable	Options	Options	Contractual
	Prices	Outstanding	Exercisable	Life (years)
	$4.05	236,667	225,001	2.23
	Total	236,667	225,001
	The stock-based compensation expense recognized in the statement of operations during the years ended December 31, 2013 and 2012, related to the granting of these options was $133,997 and 273,832.
	Warrants
	During the years ended December 31, 2013 and 2012, the Company granted 0 and 150,000 warrants, respectively. As of December 31, 2013, 245,000 warrants are outstanding.  The warrant terms are 5 years with 95,000 warrants expiring in October 2016 and 150,000 warrants expiring in October 2017.
		12/31/13		12/31/12
			Weighted		Weighted
		Number	average	Number	average
		of	exercise	of	exercise
		Warrants	price	Warrants	price
	Outstanding, beginning of period	245,000	$0.97	95,000	$1.80
	Granted	-	-	150,000	0.55
	Exercised	-	-	-	-
	Expired	-	-	-	-
	Outstanding, end of period	245,000	$0.97	245,000	$0.97
	Exercisable at the end of period	245,000	$0.97	245,000	$0.97

5_Convertible_Promissory_Notes

5. Convertible Promissory Notes	12 Months Ended
	Dec. 31, 2013
Notes	'
5. Convertible Promissory Notes	'
	5.     CONVERTIBLE PROMISSORY NOTES
	During the year ended December 31, 2012, the Company entered into two securities purchase agreements each providing for the sale by the Company of 8% unsecured Convertible Notes in the principal amounts of $42,500, and $32,500 for an aggregate total of $75,000. The notes matured on July 5, 2013, and August 14, 2013. After one hundred and eighty days (180) the holder converted both notes with an aggregate principal amount of $75,000, plus accrued interest of $3,000 on various dates during the year ended December 31, 2013 into 392,788 shares of common stock at fair value ranging from $0.29 to $0.80 per share. The Company recognized a loss upon conversion of $89,162. The Company recorded debt discount of $55,493 related to the conversion feature of the notes, along with derivative liabilities at inception. During the year ended December 31, 2013, the debt discount was amortized, and recorded as interest expense in the amount of $55,493, resulting in a net debt discount of $0 at December 31, 2013.
	On January 18, 2013, the Company entered into a securities purchase agreement for the sale of 10% convertible promissory note for the aggregate principal amount of $80,000, to be advanced in amounts at the lender’s discretion.  Upon execution of the securities purchase agreement, the Company received an advance of $10,000.  On April 16, 2013, the Company received an additional advance of $25,000. The total advances received as of December 31, 2013 was $35,000, of which $10,000 in principal, and $687 in accrued interest was converted into 106,877 shares of common stock at fair value of $0.43 per share on September 29, 2013. The Company recognized a loss upon conversion of $35,269. During the month of July 2013, the Company extended the maturity date of the note from six (6) months to eighteen (18) months from the effective date of each advance. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of a) $0.40 per share b) fifty percent (50%) of the lowest trading price of common stock recorded on any trade day after the effective date, or c) the lowest effective price per share granted after the effective date. The fair value of the notes has been determined by using Black-Scholes pricing model with an expected life of more than a year. The Company recorded debt discount of $35,000 related to the conversion feature of the notes, along with derivative liabilities at inception. During the year ended December 31, 2013, the debt discount was amortized, and recorded as interest expense in the amount of $27,264, resulting in a remaining net debt discount of $7,736 at December 31, 2013.
	On March 1, 2013, the Company entered into a securities purchase agreement, providing for the sale by the Company of a 10% unsecured Convertible Note in the aggregate principal amount of $100,000, to be advanced in amounts at the lender’s discretion. Upon execution of the securities purchase agreement, the Company received an advance of $10,000. On March 20, 2013, the Company received an additional advance of $25,000. The total advances received as of December 31, 2013 was $35,000. The note matures one (1) year from the effective date of each advance. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.20 per share or fifty percent (50%) of the lowest trading price recorded on any trade day after the effective date. The fair value of the note has been determined by using the Black-Scholes pricing model with an expected life of a year. The Company recorded debt discount of $35,000 related to the conversion feature of the note, along with derivative liability at inception. During the year ended December 31, 2013, the debt discount was amortized, and recorded as interest expense in the amount of $27,945, resulting in a remaining net debt discount of $7,055 at December 31, 2013.
	On May 1, 2013, the Company entered into a securities purchase agreement for the sale of an 8% convertible promissory note for the aggregate principal amount of $32,500. In the month of November 2013, the holder converted the note in full for principal of $32,500, plus accrued interest of $1,300 into 170,647 shares of the Company’s common stock. The Company recognized a loss upon conversion of $34,348. The Company recorded a debt discount of $32,492 related to the conversion feature of the note, along with a derivative liability at inception. During the year ended December 31, 2013, the debt discount was amortized, and recorded as interest expense in the amount of $32,492, resulting in a remaining net debt discount of $0 at December 31, 2013.
	On May 13, 2013, the Company entered into a securities purchase agreement for the sale of a 10% convertible promissory note in the aggregate principal amount of $80,000, to be advanced in amounts at the lender’s discretion. Upon execution of the securities purchase agreement, the Company received an advance of $25,000.  On November 13, 2013, the holder converted the $25,000 in principal, plus accrued interest of $1,250 into 262,500 shares of the Company’s common stock at fair value of $0.50 per share. The Company recognized a loss upon conversion of $104,974. The Company recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the year ended December 31, 2013, the debt discount was amortized, and recorded as interest expense in the amount of $25,000, resulting in a remaining net debt discount of $0 at December 31, 2013.
	On June 5, 2013, the Company issued two 5% convertible promissory notes in exchange for services rendered by the Company’s Chief Executive Officer ($114,000) and Chief Technology Officer ($128,000) in the aggregate amount of $242,000. The notes are convertible into shares of common stock of the Company at a conversion price equal to the lesser of $0.24 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The notes mature two (2) years from their effective dates. The fair value of the notes has been determined by using the Black-Scholes pricing model with an expected life of two (2) years. The Company recorded a debt discount of $160,479 related to the conversion feature of the note, along with a derivative liability at inception.  During the year ended December 31, 2013, the debt discount was amortized, and recorded as interest expense in the amount of $45,945, resulting in a remaining net debt discount of $114,534 at December 31, 2013.
	On June 21, 2013, the Company entered into a securities purchase agreement for the sale of a 10% convertible promissory note in the aggregate principal amount of $100,000, to be advanced in amounts at the lender’s discretion. Upon execution of the securities purchase agreement, the Company received an advance of $25,000.  On July 26, 2013, the Company received an additional advance of $25,000. The total advances received on the note as of December 31, 2013 was $50,000. The note matures one (1) year from the effective date of each advance. On December 5, 2013, the Company amended the note and replaced the conversion price to the lesser of $0.40 per share and substituted the 50% of the lowest trade price recorded prior to conversion, to 50% of the average three (3) lowest trade prices recorded during the twenty-five (25) previous trading days. The modification was analyzed under ASC 470-50, to determine if the change in fair value of the conversion feature was greater than 10% of the carrying value of the debt. As a result, in accordance with ASC 470-50, the Company deemed the terms of the amendment not be substantially different and treated the convertible note as a modification rather than an extinguishment. On December 27, 2013, the holder converted $5,000 in principal for 143,425 shares of common stock. The Company recognized a loss of $19,123. The fair value of the note has been determined by using the Black-Scholes pricing model with an expected life of one (1) year. The Company recorded a debt discount of $50,000 related to the conversion feature of the note, along with a derivative liability at inception. During the year ended December 31, 2013, the debt discount was amortized, and recorded as interest expense in the amount of $26,397, resulting in a remaining net debt discount of $23,603 at December 31, 2013.
	We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory note was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable so they did not meet the conditions set forth in current accounting standards for equity classification.  The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations.

6_Derivative_Liabilities

6. Derivative Liabilities	12 Months Ended
	Dec. 31, 2013
Notes	'
6. Derivative Liabilities	'
	6.     DERIVATIVE LIABILITIES
	The convertible notes issued and described in Note 5 do not have fixed settlement provisions because their conversion prices are not fixed. The conversion feature has been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.  At December, 31, 2012, there were no outstanding convertible notes accounted for as derivative liabilities.
	During the year ended December 31, 2013, as a result of convertible notes (“Notes”) we issued that were accounted for as derivative liabilities, we determined that the fair value of the conversion feature of the convertible notes at issuance was $455,786, based upon a Black-Sholes-Model calculation. We recorded the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the Notes. As the aggregate fair value of these liabilities of exceeded the aggregate Note value, the excess of the liability over the Note value of $62,321 was considered as a cost of the private placement and reported in the accompanying Statement of Operations as part of the change in derivative liability.
	During the year ended December 31, 2013, approximately $147,500 convertible notes were converted.  As a result of the conversion of these notes, the Company recorded a reduction of $282,877 due to the extinguishment of the corresponding derivative liability.  Furthermore, during the year ended December 31, 2013, the Company recognized a loss of $188,261 to account for the change in fair value of the derivative liabilities.  At December 31, 2013, the fair value of the derivative liability was $361,170.
	For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used Black Scholes option valuation model. The significant assumptions used in the Black Scholes valuation of the derivative are as follows:
	Risk free interest rate	0.04% - 0.38
	Stock volatility factor	65.07% - 274.85
	Weighted average expected option life	6 months - 2 years
	Expected dividend yield	None

7_Intangible_Assets

7. Intangible Assets	12 Months Ended
	Dec. 31, 2013
Notes	'
7. Intangible Assets	'
	7.    INTANGIBLE ASSETS
	The Company has patent applications to protect the inventions and processes behind its proprietary bio-based backsheet, a protective covering for the back of photovoltaic solar cells traditionally made from petroleum-based film. During the years ended December 31, 2013 and 2012, the Company reviewed the capitalized patents for impairment in accordance with ASC 350, and determined there was no impairment.  As of December 31, 2013 and 2012, the carrying value of the patents was $47,098 and $41,290, respectively. As of December 31, 2013 and 2012, no amortization has been expensed for the patents, since approval of the patents are pending.

8_Income_Taxes

8. Income Taxes	12 Months Ended
	Dec. 31, 2013
Notes	'
8. Income Taxes	'
	8.   INCOME TAXES
	The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2010.
	Deferred income taxes have been provided by temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. To the extent allowed by GAAP, we provide valuation allowances against the deferred tax assets for amounts when the realization is uncertain. Included in the balances at December 31, 2013 and 2012, are no tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility.  Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period.
	The Company's policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the periods ended December 31, 2013 and 2012, the Company did not recognize interest or penalties.
	At December 31, 2013, the Company had net operating loss carry-forwards of approximately $5,783,000, which expire starting in 2026. No tax benefit has been reported in the December 31, 2013 and 2012 financial statements, since the potential tax benefit is offset by a valuation allowance of the same amount.
	The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended December 31, 2013 and 2012 due to the following:
		2013	2012
	Net loss	($480,230)	($399,000)
	Depreciation	-720	-840
	Meals and entertainment	530	400
	Stock compensation and other non-cash expenses	250,040	111,400
	Accrued payroll	-53,600	66,500
	Valuation Allowance	283,980	221,540
	Income tax expense	$-	$-
	Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases.
	Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	Net deferred tax liabilities consist of the following components as of December 31, 2013 and 2012:
		2013	2012
	Deferred tax assets:
	NOL carryover	$2,021,190	$1,926,100
	R & D credit	45,990	44,400
	Accrued payroll	36,000	70,000
	Deferred tax liabilities:
	Depreciation	-7,240	-7,000
	Less Valuation Allowance	-2,095,940	-2,033,500
	Net deferred tax asset	$-	$-
	Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forwards may be limited as to use in future years.
	The Company’s tax returns for the previous three years remain open for audit by the respective tax jurisdictions.

9_Commitments_and_Litigations

9. Commitments and Litigations	12 Months Ended
	Dec. 31, 2013
Notes	'
9. Commitments and Litigations	'
	9.     COMMITMENTS AND LITIGATIONS
	The Company’s facility is leased[S.K.1]  on a month to month basis without an expiration date. Our monthly lease payment is $534.  The rent paid for both years ended December 31, 2013 and 2012 were $6,408, respectively.
	We are not currently a party to, nor is any of our property currently the subject of, any pending legal proceeding that will have a material adverse effect on our business.

10_Subsequent_Event

10. Subsequent Event	12 Months Ended
	Dec. 31, 2013
Notes	'
10. Subsequent Event	'
	10.   SUBSEQUENT EVENT
	Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events:
	On January 15, 2014, the Company issued 222,134 shares of common stock upon partial conversion of a convertible note in the amount of $10,000 in principal, plus $570 ofaccrued interest.
	On January 30, 2014, the Company issued 229,674 shares of common stock upon partial conversion of a convertible note in the amount of $10,000 in principal, plus $611 of accrued interest.
	On February 24, 2014, the Company and holder of a convertible note with a maturity date of the February 28, 2014 agreed to extend the maturity date to August 28, 2104. All other terms and conditions of the note remain the same.
	On March 5, 2014, the Company issued 378,650 shares of common stock upon partial conversion of a convertible note issued to the Chief Financial Officer in the amount of $30,000 in principal, plus $1,125 of accrued interest.
	On March 5, 2014, the Company issued 315,541 shares of common stock upon partial conversion of a convertible note issued to the Chief Technology Officer in the amount of $25,000 in principal, plus $937.50 of accrued interest.

2_Summary_of_Significant_Accou1

2. Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Development Stage Activities and Operations	'
	Development Stage Activities and Operations
	The Company is in its initial stages of formation and has not had significant revenues. A development stage activity is one in which all efforts are devoted substantially to establishing a new business and even if planned principal operations have commenced, revenues are insignificant.
Revenue Recognition	'
	Revenue Recognition
	The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date, the Company has not had significant revenues and is in the development stage.
Cash and Cash Equivalent	'
	Cash and Cash Equivalent
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Investments	'
	Investments
	Certificate of Deposits with banking institutions are short-term investments with initial maturities of more than 90 days. The carrying amount of these investments is a reasonable estimate of fair value due to their short-term nature.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements.  Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, and the fair value of stock options. Actual results could differ from those estimates.
Property and Equipment	'
	Property and Equipment
	Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives:
	Computer equipment	5 Years
	Machinery & equipment	10 Years
	Depreciation expense for the years ended December 31, 2013 and 2012 was $8,203 and $8,055, respectively.
Intangible Assets	'
	Intangible Assets
	Intangible assets consist of patents that are initially measured at the lower of cost or fair value.  The patents are deemed to have an indefinite life and are not amortized. The patents are assessed annually for impairment, or whenever conditions indicate the asset may be impaired, and any such impairment will be recognized in the period identified.
Stock-based Compensation	'
	Stock-Based Compensation
	The Company measures the cost of employee services received in exchange for an equity award based on the grant-date fair value of the award. All grants under our stock-based compensation programs are accounted for at fair value and that cost is recognized over the period during which an employee is required to provide service in exchange for the award (the vesting period).
	Compensation expense for options granted to non-employees is determined in accordance with the standard as the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measured. Compensation expense for awards granted to non-employees is re-measured each period.
	Determining the appropriate fair value of the stock-based compensation requires the input of subjective assumptions, including the expected life of the stock-based payment and stock price volatility.  The Company uses the Black-Scholes option-pricing model to value its stock option awards which incorporate the Company’s stock price, volatility, U.S. risk-free rate, dividend rate, and estimated life.
Loss Per Share Calculations	'
	Loss per Share Calculations
	Loss per Share dictates the calculation of basic earnings per share and diluted earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. No shares for employee options or warrants were used in the calculation of the loss per share as they were all anti-dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the years ended December 31, 2013 and 2012, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company has excluded 611,667 exercisable options and 245,000 warrants for the year ended December 31, 2013. The Company has excluded 236,667 exercisable options and 245,000 warrants for the year ended December 31, 2012.
		For the years ended
		December 31,
		2013	2012
	(Loss) to common shareholders (Numerator)	($1,200,576)	($997,510)
	Basic and diluted weighted average number of common shares outstanding (Denominator)	7,601,521	6,434,413
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2013, the amounts reported for cash, inventory, prepaid expenses, accounts payable, and accrued expenses, approximate the fair value because of their short maturities.
	We adopted ASC Topic 820 (originally issued as SFAS 157, “Fair Value Measurements”) for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:
	·       Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
	·       Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
	·       Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at  December 31, 2013:
		Total	(Level 1)	(Level 2)	(Level 3)
	Assets	$-	$-	$-	$-
	Total assets measured at fair value	$-	$-	$-	$-
	Liabilities
	Derivative Liability	$361,170	$-	$-	$361,170
	Total liabilities measured at fair value	$361,170	$-	$-	$361,170
	The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:
	Beginning balance as of January 1, 2013	$-
	Fair value of derivative liabilities issued	455,786
	Conversion of notes payable	-282,877
	Loss on change in derivative liability	188,261
	Ending balance as of December 31, 2013	$361,170
Research and Development	'
	Research and Development
	Research and development costs are expensed as incurred.  Total research and development costs were $27,953 and $78,527 for the years ended December 31, 2013 and 2012, respectively.
Income Taxes	'
	Income Taxes
	Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.
	When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained.  The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.  Tax positions taken are not offset or aggregated with other positions.  Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority.  The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.
Recently Issued Accounting Pronouncements	'
	Recently Issued Accounting Pronouncements
	Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying consolidated financial statements.

2_Summary_of_Significant_Accou2

2. Summary of Significant Accounting Policies: Property and Equipment: Property, Plant and Equipment, Estimated Useful Lives (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Property, Plant and Equipment, Estimated Useful Lives	'
	Computer equipment	5 Years
	Machinery & equipment	10 Years

2_Summary_of_Significant_Accou3

2. Summary of Significant Accounting Policies: Loss Per Share Calculations: Schedule of Calculation of Numerator and Denominator in Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Calculation of Numerator and Denominator in Earnings Per Share	'
		For the years ended
		December 31,
		2013	2012
	(Loss) to common shareholders (Numerator)	($1,200,576)	($997,510)
	Basic and diluted weighted average number of common shares outstanding (Denominator)	7,601,521	6,434,413

2_Summary_of_Significant_Accou4

2. Summary of Significant Accounting Policies: Fair Value of Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	'
		Total	(Level 1)	(Level 2)	(Level 3)
	Assets	$-	$-	$-	$-
	Total assets measured at fair value	$-	$-	$-	$-
	Liabilities
	Derivative Liability	$361,170	$-	$-	$361,170
	Total liabilities measured at fair value	$361,170	$-	$-	$361,170

2_Summary_of_Significant_Accou5

2. Summary of Significant Accounting Policies: Fair Value of Financial Instruments: Schedule of Derivative Liabilities at Fair Value (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Derivative Liabilities at Fair Value	'
	Beginning balance as of January 1, 2013	$-
	Fair value of derivative liabilities issued	455,786
	Conversion of notes payable	-282,877
	Loss on change in derivative liability	188,261
	Ending balance as of December 31, 2013	$361,170

4_Stock_Options_and_Warrants_S

4. Stock Options and Warrants: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	'
		12/31/13	12/31/12
	Risk free interest rate	0.75%	2.14%
	Stock volatility factor	82.00%	1.00%
	Weighted average expected option life	5 years	5 years
	Expected dividend yield	None	None

4_Stock_Options_and_Warrants_S1

4. Stock Options and Warrants: Schedule of Share-based Compensation, Stock Options, Activity (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Share-based Compensation, Stock Options, Activity	'
		12/31/13		12/31/12
			Weighted		Weighted
		Number	average	Number	average
		of	exercise	of	exercise
		Options	price	Options	price
	Outstanding, beginning of period	236,667	$4.05	236,667	$4.05
	Granted	600,000	0.4	-	-
	Exercised	-	-	-	-
	Expired	-	-	-	-
	Outstanding, end of period	836,667	$1.43	236,667	$4.05
	Exercisable at the end of period	611,667	$1.81	225,001	$4.05

4_Stock_Options_and_Warrants_S2

4. Stock Options and Warrants: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range, December 31, 2013 (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range, December 31, 2013	'
	The weighted average remaining contractual life of options outstanding as of December 31, 2013 was as follows:
				Weighted
				Average
		Stock	Stock	Remaining
	Exercisable	Options	Options	Contractual
	Prices	Outstanding	Exercisable	Life (years)
	$4.05	236,667	236,667	2.23
	$0.40	600,000	375,000	4.17
	Total	836,667	611,667
	The weighted average remaining contractual life of options outstanding as of December 31, 2012 was as follows:
				Weighted
				Average
		Stock	Stock	Remaining
	Exercisable	Options	Options	Contractual
	Prices	Outstanding	Exercisable	Life (years)
	$4.05	236,667	225,001	2.23
	Total	236,667	225,001

4_Stock_Options_and_Warrants_S3

4. Stock Options and Warrants: Schedule of Warrants (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Warrants	'
		12/31/13		12/31/12
			Weighted		Weighted
		Number	average	Number	average
		of	exercise	of	exercise
		Warrants	price	Warrants	price
	Outstanding, beginning of period	245,000	$0.97	95,000	$1.80
	Granted	-	-	150,000	0.55
	Exercised	-	-	-	-
	Expired	-	-	-	-
	Outstanding, end of period	245,000	$0.97	245,000	$0.97
	Exercisable at the end of period	245,000	$0.97	245,000	$0.97

6_Derivative_Liabilities_Fair_

6. Derivative Liabilities: Fair Value Assumptions of Derivative Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Fair Value Assumptions of Derivative Liabilities	'
	Risk free interest rate	0.04% - 0.38
	Stock volatility factor	65.07% - 274.85
	Weighted average expected option life	6 months - 2 years
	Expected dividend yield	None

8_Income_Taxes_Schedule_of_Eff

8. Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Effective Income Tax Rate Reconciliation	'
		2013	2012
	Net loss	($480,230)	($399,000)
	Depreciation	-720	-840
	Meals and entertainment	530	400
	Stock compensation and other non-cash expenses	250,040	111,400
	Accrued payroll	-53,600	66,500
	Valuation Allowance	283,980	221,540
	Income tax expense	$-	$-

8_Income_Taxes_Schedule_of_Def

8. Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Deferred Tax Assets and Liabilities	'
		2013	2012
	Deferred tax assets:
	NOL carryover	$2,021,190	$1,926,100
	R & D credit	45,990	44,400
	Accrued payroll	36,000	70,000
	Deferred tax liabilities:
	Depreciation	-7,240	-7,000
	Less Valuation Allowance	-2,095,940	-2,033,500
	Net deferred tax asset	$-	$-

1_Organization_and_Line_of_Bus1

1. Organization and Line of Business (Details)	12 Months Ended
	Dec. 31, 2013
Details	'
Date of Incorporation	24-Apr-06

2_Summary_of_Significant_Accou6

2. Summary of Significant Accounting Policies: Property and Equipment: Property, Plant and Equipment, Estimated Useful Lives (Details)	12 Months Ended
	Dec. 31, 2013
Computer Equipment	'
Property, Plant and Equipment, Useful Life	'5 years
Machinery and Equipment	'
Property, Plant and Equipment, Useful Life	'10 years

2_Summary_of_Significant_Accou7

2. Summary of Significant Accounting Policies: Property and Equipment (Details) (USD $)	12 Months Ended		92 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Details	'	'	'
Depreciation expense	$8,203	$8,055	$42,996

2_Summary_of_Significant_Accou8

2. Summary of Significant Accounting Policies: Loss Per Share Calculations (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Stock Options	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	611,667	236,667
Warrant	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	245,000	245,000

2_Summary_of_Significant_Accou9

2. Summary of Significant Accounting Policies: Loss Per Share Calculations: Schedule of Calculation of Numerator and Denominator in Earnings Per Share (Details) (USD $)	9 Months Ended	12 Months Ended							92 Months Ended
	Dec. 31, 2006	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2007	Dec. 31, 2013
Details	'	'	'	'	'	'	'	'	'
(Loss) to common shareholders (Numerator)	($274,361)	($1,200,576)	($997,510)	($1,147,062)	($919,393)	($644,601)	($947,646)	($847,706)	($6,978,855)
Basic and diluted weighted average number of common shares outstanding (Denominator)	'	7,601,521	6,434,413	'	'	'	'	'	'

Recovered_Sheet1

2. Summary of Significant Accounting Policies: Fair Value of Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) (USD $)	Dec. 31, 2013
Assets	$0
Liabilities	'
Derivative Liability	361,170
Total liabilities measured at fair value	361,170
Fair Value, Inputs, Level 1	'
Assets	0
Liabilities	'
Derivative Liability	0
Total liabilities measured at fair value	0
Fair Value, Inputs, Level 2	'
Assets	0
Liabilities	'
Derivative Liability	0
Total liabilities measured at fair value	0
Fair Value, Inputs, Level 3	'
Assets	0
Liabilities	'
Derivative Liability	361,170
Total liabilities measured at fair value	$361,170

Recovered_Sheet2

2. Summary of Significant Accounting Policies: Fair Value of Financial Instruments: Schedule of Derivative Liabilities at Fair Value (Details) (USD $)	12 Months Ended	92 Months Ended
	Dec. 31, 2013	Dec. 31, 2013
Details	'	'
Beginning balance	$0	'
Fair value of derivative liabilities issued	455,786	'
Conversion of Notes Payable	-282,877	'
Loss on change in derivative liability	188,261	188,261
Ending balance	$361,170	$361,170

Recovered_Sheet3

2. Summary of Significant Accounting Policies: Research and Development (Details) (USD $)	12 Months Ended		92 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Details	'	'	'
Research and development	$27,953	$78,527	$842,310

3_Capital_Stock_Details

3. Capital Stock (Details) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

Dec. 31, 2012

Sep. 30, 2012

Mar. 31, 2012

Dec. 31, 2006

Sep. 30, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2007

Common Stock, shares authorized

500,000,000

'

'

'

'

500,000,000

500,000,000

'

'

'

'

'

Common Stock, par or stated value

$0.00

'

'

'

'

$0.00

$0.00

'

'

'

'

'

Preferred Stock, shares authorized

10,000,000

'

'

'

'

10,000,000

10,000,000

'

'

'

'

'

Preferred Stock, par or stated value

$0.00

'

'

'

'

$0.00

$0.00

'

'

'

'

'

Issuance of common stock for cash, Shares

149,714

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock for cash, Value

'

$815

'

$1,439,278

'

$398,291

$337,865

$738,301

$450,000

$517,000

$390,000

$531,000

Issuance of common shares for converted promissory notes at fair value, Shares

'

'

'

'

'

1,076,237

'

'

'

'

'

'

Debt Conversion, Original Debt, Amount

'

'

'

'

'

147,500

'

'

'

'

'

'

Issuance of common stock for subscription receivable, Shares

'

'

18,812

'

'

'

'

'

'

'

'

'

Issuance of common stock for subscription receivable, Value

'

'

12,416

'

'

'

11,601

'

'

'

'

'

Cancellation of subscription receivable, Value

'

'

'

'

11,601

'

-11,601

'

'

'

'

'

Cancellation of subscription receivable, Shares

'

'

'

'

17,577

'

'

'

'

'

'

'

Issuance of common stock for warrants through a cashless exercise, Shares

'

'

'

'

'

'

332,602

'

'

'

'

'

Accrued Interest Converted

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Original Debt, Amount

'

'

'

'

'

6,497

'

'

'

'

'

'

Minimum

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price

'

'

'

'

'

$0.10

'

'

'

'

'

'

Maximum

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price

'

'

'

'

'

$0.39

'

'

'

'

'

'

Purchase 1

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock for cash, Shares

'

'

'

'

'

504,773

376,818

'

'

'

'

'

Equity Issuance, Per Share Amount

'

'

'

'

'

$0.22

$0.55

'

'

'

'

'

Issuance of common stock for cash, Value

'

'

'

'

'

111,050

207,250

'

'

'

'

'

Purchase 2

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock for cash, Shares

'

'

'

'

'

1,025,858

37,880

'

'

'

'

'

Equity Issuance, Per Share Amount

'

'

'

'

'

$0.28

$0.66

'

'

'

'

'

Issuance of common stock for cash, Value

'

'

'

'

'

287,241

25,000

'

'

'

'

'

Purchase 3

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock for cash, Shares

'

'

'

'

'

'

1,235

'

'

'

'

'

Equity Issuance, Per Share Amount

'

'

'

'

'

'

$0.66

'

'

'

'

'

Issuance of common stock for cash, Value

'

'

'

'

'

'

815

'

'

'

'

'

Purchase 4

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock for cash, Shares

'

'

'

'

'

'

149,714

'

'

'

'

'

Equity Issuance, Per Share Amount

'

'

'

'

'

'

$0.70

'

'

'

'

'

Issuance of common stock for cash, Value

'

'

'

'

'

'

$104,799

'

'

'

'

'

4_Stock_Options_and_Warrants_S4

4. Stock Options and Warrants: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Risk Free Interest Rate	0.75%	2.14%
Stock volatility factor	82.00%	1.00%
Weighted average expected option life	'5 years	'5 years
Expected dividend yield	$0	$0

4_Stock_Options_and_Warrants_S5

4. Stock Options and Warrants: Schedule of Share-based Compensation, Stock Options, Activity (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Outstanding, beginning of period	236,667	236,667
Outstanding, Weighted average exercise price, beginning of period	$4.05	$4.05
Granted	600,000	0
Granted, Weighted average exercise price	$0.40	$0
Exercised	0	0
Exercised, Weighted average exercise price	$0	$0
Expired	0	0
Expired, Weighted average exercise price	$0	$0
Outstanding, end of period	836,667	236,667
Outstanding, Weighted average exercise price, end of period	$1.43	$4.05
Exercisable at the end of period	611,667	225,001
Exercisable, Weighted average exercise price	$1.81	$4.05

4_Stock_Options_and_Warrants_S6

4. Stock Options and Warrants: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range, December 31, 2013 (Details)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
	4.05	4.05	0.4
Stock Options Outstanding	836,667	236,667	600,000
Stock Options Exercisable	611,667	225,001	375,000
Weighted Average Remaining Contractual Life (years)	'	'	'4 years 2 months 1 day
Stock Options Outstanding	836,667	236,667	600,000
Stock Options Exercisable	611,667	225,001	375,000
Weighted Average Remaining Contractual Life (years)	'	'	'4 years 2 months 1 day

4_Stock_Options_and_Warrants_D

4. Stock Options and Warrants (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Warrants Granted	0	150,000
Warrants, Outstanding	245,000	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	'5 years	'
October 2016 Expiration Date	'	'
Warrants, Outstanding	95,000	'
October 2017 Expiration Date	'	'
Warrants, Outstanding	150,000	'
Stock Options	'	'
Allocated Share-based Compensation Expense	133,997	273,832

4_Stock_Options_and_Warrants_S7

4. Stock Options and Warrants: Schedule of Warrants (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Outstanding, beginning of period	245,000	95,000
Outstanding, Weighted average exercise price, beginning of period	$0.97	$1.80
Granted	0	150,000
Granted, Weighted average exercise price	$0	$0.55
Exercised	0	0
Exercised, Weighted average exercise price	$0	$0
Expired	0	0
Expired, Weighted average exercise price	$0	$0
Outstanding, end of period	245,000	245,000
Outstanding, Weighted average exercise price, end of period	$0.97	$0.97
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable	245,000	245,000
Exercisable at the end of period, Weighted average exercise price	$0.97	$0.97

5_Convertible_Promissory_Notes1

5. Convertible Promissory Notes (Details) (USD $)

12 Months Ended

92 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Aug. 14, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Jan. 18, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Mar. 01, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

2-May-13

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

13-May-13

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Jun. 05, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Jun. 21, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Minimum

Maximum

Accrued Interest Converted

Securities Purchase Agreements Unsecured Convertible Notes 1

Securities Purchase Agreements Unsecured Convertible Notes 1

Securities Purchase Agreements Unsecured Convertible Notes 1

Securities Purchase Agreements Unsecured Convertible Notes 1

Securities Purchase Agreements Unsecured Convertible Notes 1

Securities Purchase Agreements Unsecured Convertible Notes 1

Securities Purchase Agreements Unsecured Convertible Note 1A

Securities Purchase Agreements Unsecured Convertible Note 1B

Securities Purchase Agreements Unsecured Convertible Notes 2

Securities Purchase Agreements Unsecured Convertible Notes 2

Securities Purchase Agreements Unsecured Convertible Notes 2

Securities Purchase Agreements Unsecured Convertible Notes 2

Securities Purchase Agreements Unsecured Convertible Notes 2

Securities Purchase Agreements Unsecured Convertible Notes 3

Securities Purchase Agreements Unsecured Convertible Notes 3

Securities Purchase Agreements Unsecured Convertible Notes 3

Securities Purchase Agreements Unsecured Convertible Notes 3

Securities Purchase Agreements Unsecured Convertible Notes 4

Securities Purchase Agreements Unsecured Convertible Notes 4

Securities Purchase Agreements Unsecured Convertible Notes 4

Securities Purchase Agreements Unsecured Convertible Notes 4

Securities Purchase Agreements Unsecured Convertible Notes 5

Securities Purchase Agreements Unsecured Convertible Notes 5

Securities Purchase Agreements Unsecured Convertible Notes 5

Securities Purchase Agreements Unsecured Convertible Notes 5

Securities Purchase Agreements Unsecured Convertible Notes 6

Securities Purchase Agreements Unsecured Convertible Notes 6

Securities Purchase Agreements Unsecured Convertible Notes 6

Securities Purchase Agreements Unsecured Convertible Notes 6

Securities Purchase Agreements Unsecured Convertible Notes 7

Securities Purchase Agreements Unsecured Convertible Notes 7

Securities Purchase Agreements Unsecured Convertible Notes 7

Securities Purchase Agreements Unsecured Convertible Notes 7

Securities Purchase Agreements Unsecured Convertible Notes 7

Minimum

Maximum

Accrued Interest Converted

Advance 1

Advance 2

Accrued Interest Converted

Advance 1

Advance 2

Principal

Interest

Principal

Interest

Chief Executive Officer

Officer

Advance 1

Advance 2

Principal

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

8.00%

'

'

'

'

'

10.00%

'

'

'

'

10.00%

'

'

'

8.00%

'

'

'

10.00%

'

'

'

'

'

5.00%

5.00%

'

10.00%

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

'

$75,000

'

'

'

$42,500

$32,500

'

'

'

'

'

'

'

'

'

$32,500

'

'

'

'

'

'

'

$242,000

'

$114,000

$128,000

'

'

'

'

'

Debt Instrument, Maturity Date

'

'

'

'

'

'

'

'

'

'

'

'

5-Jul-13

14-Aug-13

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Original Debt, Amount

147,500

'

'

'

'

6,497

75,000

'

'

'

'

3,000

'

'

10,000

'

'

'

687

'

'

'

'

'

'

32,500

1,300

'

'

25,000

1,250

'

'

'

'

'

'

'

'

5,000

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

'

'

'

392,788

'

'

'

'

'

'

'

106,877

'

'

'

'

'

'

'

'

'

'

'

170,647

262,500

'

'

'

'

'

'

'

143,425

'

'

'

'

Debt Instrument, Convertible, Conversion Price

'

'

'

$0.10

$0.39

'

'

'

'

$0.29

$0.80

'

'

'

$0.43

'

'

'

'

'

'

'

'

'

'

'

'

$0.50

'

'

'

'

'

'

'

'

'

'

'

'

Loss Upon Conversion of Promissory Notes

89,162

'

'

'

'

'

'

'

'

'

'

'

'

'

35,269

'

'

'

'

'

'

'

'

34,348

'

'

'

104,974

'

'

'

'

'

'

'

19,123

'

'

'

'

Debt Instrument, Unamortized Discount

152,928

20,369

152,928

'

'

'

0

55,493

'

'

'

'

'

'

7,736

35,000

'

'

'

7,055

35,000

'

'

0

32,492

'

'

0

25,000

'

'

114,534

160,479

'

'

23,603

50,000

'

'

'

Amortization of debt discount recognized as interest expense

307,442

'

307,442

'

'

'

55,493

'

'

'

'

'

'

'

27,264

'

'

'

'

27,945

'

'

'

32,492

'

'

'

25,000

'

'

'

45,945

'

'

'

26,397

'

'

'

'

Securities Purchase Agreement Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

80,000

'

'

'

'

100,000

'

'

'

'

'

'

'

80,000

'

'

'

'

'

'

'

100,000

'

'

'

'

Proceeds from convertible promissory notes

$177,500

$75,000

$252,500

'

'

'

'

'

'

'

'

'

'

'

$35,000

'

$10,000

$25,000

'

$35,000

'

$10,000

$25,000

'

'

'

'

$25,000

'

'

'

'

'

'

'

$50,000

'

$25,000

$25,000

'

Debt Instrument, Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'During the month of July 2013, the Company extended the maturity date of the note from six (6) months to eighteen (18) months from the effective date of each advance. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of a) $0.40 per share b) fifty percent (50%) of the lowest trading price of common stock recorded on any trade day after the effective date, or c) the lowest effective price per share granted after the effective date.

'

'

'

'

'

'

'

'

'The note matures one (1) year from the effective date of each advance. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.20 per share or fifty percent (50%) of the lowest trading price recorded on any trade day after the effective date.

'

'

'

'

'

'

'

'The notes are convertible into shares of common stock of the Company at a conversion price equal to the lesser of $0.24 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The notes mature two (2) years from their effective dates.

'

'

'

'The note matures one (1) year from the effective date of each advance. On December 5, 2013, the Company amended the note and replaced the conversion price to the lesser of $0.40 per share and substituted the 50% of the lowest trade price recorded prior to conversion, to 50% of the average three (3) lowest trade prices recorded during the twenty-five (25) previous trading days. The modification was analyzed under ASC 470-50, to determine if the change in fair value of the conversion feature was greater than 10% of the carrying value of the debt. As a result, in accordance with ASC 470-50, the Company deemed the terms of the amendment not be substantially different and treated the convertible note as a modification rather than an extinguishment.

'

'

'

'

Fair Value Assumptions, Expected Term, Simplified Method

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'expected life of more than a year.

'

'

'

'

'expected life of a year.

'

'

'

'

'

'

'

'

'

'

'

'expected life of two (2) years.

'

'

'

'expected life of one (1) year

'

'

'

'

6_Derivative_Liabilities_Detai

6. Derivative Liabilities (Details) (USD $)	12 Months Ended	92 Months Ended
	Dec. 31, 2013	Dec. 31, 2013	Jun. 30, 2013
Fair value of derivative liabilities issued	$361,170	$361,170	$455,786
Convertible notes converted, Value	436,873	'	'
Fair value of derivative liabilities issued	455,786	'	'
Loss on change in derivative liability	188,261	188,261	'
Convertible Debt	'	'	'
Amortization of Financing Costs	62,321	'	'
Convertible notes converted, Value	147,500	'	'
Fair value of derivative liabilities issued	$282,877	'	'

6_Derivative_Liabilities_Fair_1

6. Derivative Liabilities: Fair Value Assumptions of Derivative Liabilities (Details)	12 Months Ended
	Dec. 31, 2013
Expected dividend yield	0.00%
Minimum	'
Risk free interest rate	0.04%
Stock volatility factor	65.07%
Weighted average expected option life	'6 months
Maximum	'
Risk free interest rate	0.38%
Stock volatility factor	274.85%
Weighted average expected option life	'2 years

7_Intangible_Assets_Details

7. Intangible Assets (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Patents	$47,098	$41,290
Amortization of Intangible Assets	$0	$0

8_Income_Taxes_Details

8. Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Details	'
Operating Loss Carryforwards	$5,783,000
Operating Loss Carryforwards, Expiration Dates	'2026

8_Income_Taxes_Schedule_of_Eff1

8. Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Net loss	($480,230)	($399,000)
Depreciation	-720	-840
Meals and Entertainment	530	400
Stock compensation and other non-cash expenses	250,040	111,400
Accrued payroll	-53,600	66,500
Valuation Allowance	283,980	221,540
Income Tax Expense (Benefit), Total	$0	$0

8_Income_Taxes_Schedule_of_Def1

8. Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred tax assets:	'	'
NOL Carryover	$2,021,190	$1,926,100
R & D credit	45,990	44,400
Accrued Payroll	36,000	70,000
Deferred tax liabilities:	'	'
Depreciation	-7,240	-7,000
Valuation Allowance	-2,095,940	-2,033,500
Net deferred tax asset	$0	$0

9_Commitments_and_Litigations_

9. Commitments and Litigations (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Operating Leases, Future Minimum Payments Due	$534	'
Operating Leases, Rent Expense, Net	$6,408	$6,408

10_Subsequent_Event_Details

10. Subsequent Event (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Debt Conversion, Original Debt, Amount	$147,500
Subsequent Event | Note 1	'
Debt Conversion, Converted Instrument, Shares Issued	222,134
Subsequent Event | Note 1 | Principal	'
Debt Conversion, Original Debt, Amount	10,000
Subsequent Event | Note 1 | Interest	'
Debt Conversion, Original Debt, Amount	570
Subsequent Event | Note 2	'
Debt Conversion, Converted Instrument, Shares Issued	229,674
Subsequent Event | Note 2 | Principal	'
Debt Conversion, Original Debt, Amount	10,000
Subsequent Event | Note 2 | Interest	'
Debt Conversion, Original Debt, Amount	611
Subsequent Event | Note 3	'
Debt Conversion, Converted Instrument, Shares Issued	378,650
Subsequent Event | Note 3 | Principal	'
Debt Conversion, Original Debt, Amount	30,000
Subsequent Event | Note 3 | Interest	'
Debt Conversion, Original Debt, Amount	1,125
Subsequent Event | Note 4	'
Debt Conversion, Converted Instrument, Shares Issued	315,541
Subsequent Event | Note 4 | Principal	'
Debt Conversion, Original Debt, Amount	25,000
Subsequent Event | Note 4 | Interest	'
Debt Conversion, Original Debt, Amount	$937.50